Penumbra, Inc. (PEN) NYSE

Currency In USD

AD

Penumbra, Inc.

Address

One Penumbra Place

Alameda, CA 94502

United States of America (the)

Phone

510 748 3200

Sector

Healthcare

Industry

Medical - Devices

Employees

4700

First IPO Date

September 18, 2015

Key Executives

NameTitlePayYear Born
Adam ElsesserCo-Founder, Chairman & Chief Executive Officer851,6201962
Arani BoseCo-Founder & Director60,0001962
Lambert ShiuChief Accounting Officer601,1411980
Johanna RobertsExecutive Vice President, General Counsel & Secretary722,3711972
Maggie S. YuenChief Financial Officer722,4671972
Shruthi NarayanPresident737,3511985
Ben TompkinsExecutive Vice President of Development & Compliance0N/A
Jason Richard MillsExecutive Vice President of Strategy0N/A
Pankaj TiwariExecutive Vice President & Chief Information Officer0N/A
Ben SorciExecutive Vice President of Operations0N/A
Jee Hamlyn-HarrisInvestor Relations Officer0N/A
AD

Description

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. It offers computer-assisted vacuum thrombectomy; peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX, BENCHMARK, BMX, DDC, Access25; MIDWAY, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization device, aspiration tubing, aspiration pump, and other components and accessories under the Penumbra RED, SENDit, JET, ACE, BMX, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that include the Penumbra Coil 400, for the treatment of aneurysms and other complex lesions, detachable coils of neurovascular lesions under the Penumbra SMART COIL, SwiftSET, and Penumbra SwiftPAC Coil brands; and POD400 and PAC400 brands. In addition, it provides peripheral embolization products, such as Ruby Embolization Platform, which consists of detachable coils for peripheral applications; Ruby LP and XL Embolization Platform; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; Packing Coil LP; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers neurosurgical tools comprising the Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. It sells its products through direct sales organizations and distributors. The company was incorporated in 2004 and is based in Alameda, California.

AD